Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upper Extremity LV-HIIT in HFpEF
NCT06754475Recruiting
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Start
- Nov 2024
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Tarsus Pharmaceuticals, Inc. Primary endpoints: Maximal Arm Exercise Capacity at 8 weeks, Functional Capacity at 8 weeks and 5 more. Started Nov 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06754475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754475.